We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+13.91%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$76.9M
AUM Growth
-$110M
Cap. Flow
+$5.55M
Cap. Flow %
7.21%
Top 10 Hldgs %
92.13%
Holding
55
New
13
Increased
3
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
EOSE icon
Eos Energy Enterprises
EOSE
+$2.76M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.93M
3
BTBT icon
Bit Digital
BTBT
+$1.87M
4
LICN icon
Lichen China
LICN
+$1.85M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$1.81M

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$1.03M
2
IMNN icon
Imunon
IMNN
+$645K
3
HCWC
Healthy Choice Wellness
HCWC
+$418K
4
SUNE
SUNation Energy
SUNE
+$373K
5
ENSC icon
Ensysce Biosciences
ENSC
+$279K

Sector Composition

Rank Sector Weight
1 Industrials 5.68%
2 Healthcare 2.8%
3 Financials 1.81%
4 Technology 0.43%
5 Consumer Discretionary 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOXO
26
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$23.5K 0.03%
+4,048
New +$29.1K
SXTPW icon
27
60 Degrees Pharmaceuticals Warrant
SXTPW
$4.81K 0.01%
161,930
-109,198
-40% -$3.16K
AMPGW
28
DELISTED
Amplitech Group Warrants
AMPGW
– –
-197,378
Closed -$7.89K
ATOS icon
29
PUT
Atossa Therapeutics
ATOS
$24.1M
– –
-1
Closed -$1.37K
BJDX icon
30
Bluejay Diagnostics
BJDX
$1.03M
– –
-1,526
Closed -$38.8K
CORZ icon
31
CALL
Core Scientific
CORZ
$6.63B
– –
-419
Closed -$497K
ELAB icon
32
Elevai Labs
ELAB
$4.3M
– –
-22
Closed -$211K
ENSC icon
33
Ensysce Biosciences
ENSC
$3.86M
– –
-77,506
Closed -$279K
FCUV icon
34
Focus Universal
FCUV
$1.48M
– –
-1,252
Closed -$132K
GLBS icon
35
PUT
Globus Maritime Ltd
GLBS
$60.9M
– –
-91
Closed -$17.5K
IMNN icon
36
Imunon
IMNN
$6.43M
– –
-46,629
Closed -$645K
KPRX icon
37
Kiora Pharmaceuticals
KPRX
$11.4M
– –
-5,000
Closed -$18.3K
NRXP icon
38
NRX Pharmaceuticals
NRXP
$152M
– –
-35,049
Closed -$59.2K
NRXP icon
39
PUT
NRX Pharmaceuticals
NRXP
$152M
– –
-768
Closed -$130K
PHIO icon
40
Phio Pharmaceuticals
PHIO
$11.7M
– –
-25,131
Closed -$86.7K
REVB icon
41
Revelation Biosciences
REVB
$4.06M
– –
-220
Closed -$36K
SCLX icon
42
Scilex Holding
SCLX
$48M
– –
-115
Closed -$3.72K
SCLX icon
43
PUT
Scilex Holding
SCLX
$48M
– –
-1
Closed -$3.98K
BNKK
44
PUT
Bonk Inc
BNKK
$8.32M
– –
-1
Closed -$3.17K
SIDU icon
45
Sidus Space
SIDU
$172M
– –
-30,098
Closed -$84.3K
SNES icon
46
SenesTech
SNES
$7.11M
– –
-55,639
Closed -$144K
SPCB icon
47
SuperCom
SPCB
$65.9M
– –
-9,360
Closed -$35.2K
VVOS icon
48
Vivos Therapeutics
VVOS
$5.84M
– –
-20,502
Closed -$53.5K
WLDSW icon
49
Wearable Devices Ltd Warrant
WLDSW
$135K
– –
-207
Closed -$2.96K
HAO icon
50
Haoxi Health Technology Ltd
HAO
$1.19M
– –
-109
Closed -$125K
1
2
3

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sabby Management held 55 positions worth $76.9M, down 59% from $186M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Sabby Management deployed $5.55M of net new capital in Q4 2024, opening 13 new positions and adding to 3 existing holdings. Its largest new stake was Eos Energy Enterprises: 853,365 shares worth $4.15M.

By sector, the portfolio is most concentrated in Industrials at 5.7% of assets, up from 0.06% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vivani Medical, an estimated $1.03M trimmed.

  • Sabby Management's largest Q4 2024 buy was Eos Energy Enterprises: 853,365 shares worth $4.15M.
  • Sabby Management's biggest Q4 2024 reduction was Vivani Medical, cutting an estimated $1.03M.
  • Sabby Management fully exited Imunon in Q4 2024, selling an estimated $645K.
  • Sabby Management's ten largest holdings make up 92% of its $76.9M portfolio in Q4 2024.
  • Sabby Management opened 13 new positions and closed 28 in Q4 2024.
  • Sabby Management's portfolio value fell 59% quarter-over-quarter to $76.9M.

Based on Sabby Management's 13F filing for Q4 2024, filed 14 Feb 2025.